With just a single droplet of blood our Biochip reader delivers reliable and fast diagnosis on a wide variety of diseases

Learn More ➝ CAMPTON Biochip Reader
CAMPTON & Corona

Developing PCR-based and serological tests for the novel coronavirus (SARS- CoV-2)

Learn More ➝

Redefining Disease Diagnosis

POC Diagnostics made

Biotechnology will change life in the 21th century at least as radically as information technology did in the 20th century. In medical applications and robotics, computer science and microelectronics will enable new analytical methods that considerably increase efficiency in areas such as pharmaceutical research, diagnosis and ultimately: Patient care.

These new methods will change the equipment used in pharmaceutical labs in the same extent as PCs changed the world of computing two decades ago: Everything used in the lab will become smaller, faster and more affordable.

Leveraging its know-how in producing micro-scale chip structures at the highest quality in large numbers, CAMPTON Diagnostics™ would like to become a driving force in this development.

Introduction

Leading Scientists at the Fraunhofer Institute for Silicon Technology (ISIT),  located in Germany, have developed a new Point-of-Care (POC) technology to identify cancer, infectious and autoimmune diseases in specialized medical practices or hospitals and clinics worldwide.

Capability

Selected examples of diseases which can be diagnosed using the CAMPTON Biochip SystemTM are:

  • Allergies
  • Infectious Diseases (like Malaria, Ebola, HCV, HIV, Zika virus)
  • Multiple Sclerosis
  • Cancer of the blood / Leukemia
  • Prostate Cancer and other diseases

Benefit

POC diagnostics are decentralized, near patient tests usually performed through the use of portable devices. The use of these tests can provide faster results, helping to improve patient care and treatment.

Quality

This system solution will be certified, produced and sold on a worldwide basis by the newly founded company CAMPTON DiagnosticsTM, which is located in Germany.

The relevant technology is patented by Fraunhofer and licensed by CAMPTON DiagnosticsTM.

News

MEDICA 2020: CAMPTON Diagnostics presents fully automated point-of-care platform for fast test results

CAMPTON Reader 100 enables the detection of biomarkers e.g. for infections, cancer, autoimmune or other diseases from a…

CAMPTON launches new website

Wir freuen uns, unsere neue Website zu eröffnen! Mit einem modernen und klaren Erscheinungsbild haben wir unsere Website…

CAMPTON at virtual.MEDICA

From 16th to 19th November, we will be presenting our CAMPTON Reader 100, a new point-of-care technology to…